tiprankstipranks
Arch Therapeutics (ARTH)
OTHER OTC:ARTH
US Market

Arch Therapeutics (ARTH) Income Statement

Compare
162 Followers

Arch Therapeutics Income Statement

Last quarter (Q3 2024), Arch Therapeutics's total revenue was $30.91K, an increase of 132.55% from the same quarter last year. In Q3, Arch Therapeutics's net income was $-5.65M. See Arch Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
$ 75.72K$ 15.65K$ 11.56K$ 0.00$ 0.00
Gross Profit
$ -2.44K$ -35.84K$ -14.72K$ -6.93K$ -8.24K
Operating Expenses
$ 5.04M$ 5.67M$ 6.36M$ 5.37M$ 6.37M
Depreciation and Amortization
$ 1.97K$ 3.20K$ 2.59K$ 6.93K$ 8.24K
EBITDA
$ -3.88M$ -4.71M$ -6.09M$ -5.35M$ -6.36M
Operating Income
$ -5.04M$ -5.71M$ -6.38M$ -5.37M$ -6.37M
Other Income/Expenses
$ -1.94M$ 432.95K$ 136.64K$ 660.74K$ 1.82M
Pretax Income
$ -6.98M$ -5.28M$ -6.24M$ -4.69M$ -4.55M
Net Income
$ -6.98M$ -4.28M$ -6.57M$ -4.01M$ -2.72M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.27$ -3.56$ -5.97$ -4.27$ -3.27
Diluted EPS
$ -2.27$ -3.56$ -5.97$ -4.27$ -3.27
Weighted Average Shares Outstanding
3.07M 1.20M 1.10M 940.26K 831.70K
Weighted Average Shares Outstanding (Diluted)
3.07M 1.20M 1.10M 940.26K 831.70K
Currency in USD

Arch Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis